BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2940560)

  • 1. [D-penicillamine and dermatopolymyositis. Value of the study of anti-JO 1 antibodies].
    Oberlin F; Koeger AC; Meyer O; Rosey T; Camus JP
    Presse Med; 1986 May; 15(19):887. PubMed ID: 2940560
    [No Abstract]   [Full Text] [Related]  

  • 2. Dermatomyositis induced by penicillamine.
    Simpson NB; Golding JR
    Acta Derm Venereol; 1979; 59(6):543-4. PubMed ID: 94219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dermatopolymyositis induced by D-penicillamine in rheumatoid polyarthritis. Apropos of 1 case with review of the literature].
    Kolsi R; Bahloul Z; Hachicha J; Gouiaa R; Jarraya A
    Rev Rhum Mal Osteoartic; 1992 May; 59(5):341-4. PubMed ID: 1411195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatomyositis complicating penicillamine treatment.
    Fernandes L; Swinson DR; Hamilton EB
    Ann Rheum Dis; 1977 Feb; 36(1):94-5. PubMed ID: 843119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penicillamine induced polymyositis and dermatomyositis.
    Carroll GJ; Will RK; Peter JB; Garlepp MJ; Dawkins RL
    J Rheumatol; 1987 Oct; 14(5):995-1001. PubMed ID: 3501473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dermatopolymyositis and D-penicillamine: value of the search for anti-JO1 antibodies].
    Koeger AC; Oberlin F; Rozenberg S; Bourgeois P
    Rev Rhum Mal Osteoartic; 1992 Nov; 59(11):774. PubMed ID: 1306601
    [No Abstract]   [Full Text] [Related]  

  • 7. D-penicillamine and polymyositis: the significance of the anti-Jo-1 antibody.
    Jenkins EA; Hull RG; Thomas AL
    Br J Rheumatol; 1993 Dec; 32(12):1109-10. PubMed ID: 8252325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatomyositis induced by penicillamine.
    Wojnarowska F
    J R Soc Med; 1980 Dec; 73(12):884-6. PubMed ID: 7452649
    [No Abstract]   [Full Text] [Related]  

  • 9. Penicillamine-induced polymyositis-dermatomyositis.
    Petersen J; Halberg P; Højgaard K; Lyon BB; Ullman S
    Scand J Rheumatol; 1978; 7(2):113-7. PubMed ID: 705267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillamine-induced dermatomyositis. A case history.
    Lund HI; Nielsen M
    Scand J Rheumatol; 1983; 12(4):350-2. PubMed ID: 6658398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penicillamine-induced myositis. Observations and unique features in two patients and review of the literature.
    Halla JT; Fallahi S; Koopman WJ
    Am J Med; 1984 Oct; 77(4):719-22. PubMed ID: 6592972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous problems with drug therapy in rheumatoid arthritis.
    Wilson CL; Bradlow A; Wojnarowska F
    Int J Dermatol; 1991 Feb; 30(2):148-9. PubMed ID: 2001908
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antibodies to D-penicillamine in patients with chronic polyarthritis--diagnostic aid in undesired and insufficient drug effects?].
    Storch W; Keitel W
    Z Rheumatol; 1988; 47 Suppl 1():44-7. PubMed ID: 3213272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cutaneous side effects induced by D-penicillamine in the treatment of rheumatoid arthritis].
    Broggini M; Baratelli E; Cappelli A; Crespi E; Filardi PG; Volontè S
    Minerva Med; 1990 Mar; 81(3):197-201. PubMed ID: 2138721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pemphigus induced by D-penicillamine in rheumatoid arthritis. Study of 5 cases and systematic study of anti-intercellular substance antibodies of the skin in the course of treatment].
    Benveniste M; Crouzet J; Homberg JC; Lessana M; Camus JP; Hewitt J
    Nouv Presse Med; 1975 Dec; 4(44):3125-8. PubMed ID: 1220709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evans' syndrome caused by D-penicillamine in rheumatoid arthritis. Value of the corticoids-danazol combination].
    Masson C; Brégeon C; Ifrah N; Berton V; Housseau F; Rénier JC
    Rev Rhum Mal Osteoartic; 1991; 58(7):519-22. PubMed ID: 1925397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic abnormalities during treatment with penicillamine].
    Recordier AM; Roux H; Mercier P; Maestracci D; Schiano A
    Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):566-70. PubMed ID: 64126
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoantibody formation in D-penicillamine-treated rheumatoid arthritis.
    Camus JP; Homberg JC; Crouzet J; Mery C; Delrieu F; Massias P; Abuaf N
    J Rheumatol Suppl; 1981; 7():80-3. PubMed ID: 6939887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [D-penicillamine induced myasthenic syndromes in rheumatoid arthritis. Two cases (author's transl)].
    Rodat O; Hamelin JP; Rossard A; Cottin S; Cler JM; Rodat G; Lemouroux P
    Nouv Presse Med; 1981 May; 10(20):1645-8. PubMed ID: 7255126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lupus biology: incidence and development in 84 rheumatoid polyarthritis patients treated with D-penicillamine].
    Clerc D; Sallière D; Segond P; Bisson M; Massias P
    Ann Med Interne (Paris); 1984; 135(6):420-6. PubMed ID: 6334465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.